retatrutide mechanism of action retatrutide clinical trials 2024 2025 Research Guide: What the Phase 2 Trial Data Reported (2026) Triple hormone receptor agonist retatrutide

It works by binding to three key hormone receptors: GIP, GLP-1, and glucagon (GCG) receptors

These medications focus on gradual weight loss and improving metabolism over time

However, not all patients can access GLP-1s at the same pace

Cela permet dviter la dgradation mcanique de la structure peptidique

These medications have pleiotropic effects, meaning they act on multiple systems in the body, including providing significant protection for the cardiovascular and renal systems

The Science Behind the Hormone GLP-1, short for Glucagon-Like Peptide-1, is a hormone produced in the intestines in response to food intake